On June 16, UBTECH fell 3.52% in regular trading, trading at HKD 109.5/share, with turnover of HKD 234 million. The decline extends a multi-session pullback following a sharp rally earlier this month.

On the news front, the stock had previously surged over 8% on strong pre-sale performance of its ultra-bionic humanoid robot, with orders exceeding 2,700 units on JD.com ahead of its June 30 official launch, as well as a strategic cooperation agreement signed with Hitachi. Short-term profit-taking pressure has resurfaced as gains accumulated from these catalysts continue to be unwound.

Additionally, market concerns over equity dilution persist following the company's earlier H-share placement at a discount exceeding 11%. Investor sentiment regarding frequent capital-raising activities remains undigested, weighing on share price recovery. Three directors and shareholders recently announced voluntary lock-up commitments for 12 months, though broader unlock pressure from post-IPO lock-up expiration continues to overhang the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)